---
title: "Calidi Biotherapeutics, Inc. (CLDI.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/CLDI.US.md"
symbol: "CLDI.US"
name: "Calidi Biotherapeutics, Inc."
industry: "生物技术"
---

# Calidi Biotherapeutics, Inc. (CLDI.US)

| Item | Detail |
|------|--------|
| Industry | 生物技术 |
| Location | 美股市场 |
| Website | [www.calidibio.com](https://www.calidibio.com) |

## Company Profile

Calidi Biotherapeutics, Inc.是一家临床阶段的免疫肿瘤学公司，开发同种异体干细胞基础和包裹病毒平台，以增强和传递溶瘤病毒。其产品管线包括 CLD-101，目前正在进行高等级胶质瘤的 1b/2 期临床试验，以及针对复发性高等级胶质瘤的 1 期剂量递增临床试验；CLD-201 产品用于实体肿瘤，如乳腺癌、头颈部鳞状细胞癌和软组织肉瘤，目前处于临床前研究阶段；CLD-301 用于多种适应症，亦处于临床前研究阶段；以及 CLD-400 用于某些肺癌和转移性实体肿瘤。该公司还提供溶瘤病毒平台，如 NeuroNova、SuperNova 和 RTNova。Calidi Bioth...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.22 | 98/604 | - | - | - |
| PB | 0.82 | 72/604 | 3.74 | 3.06 | 1.23 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-07-22T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.79 |
| Highest Target | 120.00 |
| Lowest Target | 120.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/CLDI.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/CLDI.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/CLDI.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.